Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544515 · ClinicalTrials.gov registry record · NA
Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03544515 is a NA study that has completed, run by Columbia University. The registered enrollment target is 32 participants.
The verdict
NCT03544515, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of the study is to observe the effects of two commonly utilized treatment modalities to treat peri-implantitis and to compare the results. The first method of treatment is debridement with curettes and ultrasonic scalers and it represents the traditional approach in the treatment of peri-implantitis. The second method of treatment involves the use of the Biolase laser in addition to the traditional approach of debriding with curettes and ultrasonic scalers. No studies exist comparing these two approaches, and this will serve as a pilot study to explore possible differences. The research hypothesis is that the addition of Er;Cr;YSGG laser is likely to be more effective in removing the microbiota from a rough implant surface, and that this will manifest with improved clinical parameters in subjects that receive this method of treatment.
Interventions
- DEVICE Er,Cr:YSGG laser
- PROCEDURE Scaling
- DEVICE Inactive Er,Cr:YSGG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2021-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03544515
The ClinicalTrials.gov registry entry for NCT03544515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Er,Cr:YSGG laser is the first listed.
NCT03544515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03544515 about?
NCT03544515 is a clinical study titled "Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase". The purpose of the study is to observe the effects of two commonly utilized treatment modalities to treat peri-implantitis and to compare the results. The first method of treatment is debridement with curettes and ultrasonic scalers and it represents the traditional approach in the treatment of peri...
What is the current status of trial NCT03544515?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-01-14. Estimated completion is 2021-08-15.
What interventions are being tested in trial NCT03544515?
The interventions under investigation include: Er,Cr:YSGG laser (DEVICE), Scaling (PROCEDURE), Inactive Er,Cr:YSGG (DEVICE).
Who is sponsoring clinical trial NCT03544515?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.